Anixa Biosciences (ANIX) vs Conexeu Sciences (CNXU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Conexeu Sciences is the larger company by market cap ($109.7 million vs $100.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIX | CNXU |
|---|---|---|
| Share price | $2.90 | $3.89 |
| Market cap | $100.82M | $109.72M |
| 1-day change | -0.34% | +12.75% |
| YTD return | -6.73% | — |
| 1-year return | -34.46% | — |
| 5-year return | -33.71% | — |
| EPS (TTM) | $-0.32 | $-0.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.46 | $18.79 |
| 52-week low | $2.32 | $3.05 |
| Distance from 52-week high | -46.89% | -79.30% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +236.21% | +414.14% |
| Average volume | 302.95K | 205.86K |
| Shares outstanding | 34.76M | 28.21M |
| Employees | 4 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Anixa Biosciences
ANIX stock →Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Conexeu Sciences
CNXU stock →Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
Health Care · Industrial Specialties
ANIX vs CNXU FAQ
Which is bigger, Anixa Biosciences or Conexeu Sciences?
Conexeu Sciences (CNXU) is larger, with a market capitalization of $109.72M compared with $100.82M for Anixa Biosciences (ANIX).
Are Anixa Biosciences and Conexeu Sciences in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Anixa Biosciences and Industrial Specialties for Conexeu Sciences.